Fagron NV (ARSUF)
25.80
-1.70
(-6.18%)
USD |
OTCM |
Oct 08, 16:00
Fagron Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2012 | 0.00% |
| June 30, 2012 | 0.00% |
| December 31, 2011 | |
| June 30, 2011 | |
| December 31, 2010 |
| Date | Value |
|---|---|
| June 30, 2010 | |
| December 31, 2009 | 0.00% |
| June 30, 2009 | 0.00% |
| December 31, 2008 | |
| June 30, 2008 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Lakefront Biotherapeutics | 24.48% |
| UCB SA - ADR | -- |
| Acro Biomedical Co. Ltd. | -- |
| Stella Diagnostics, Inc. | -14.09% |